Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 14, 2019 at 08:21 pm IST
Share
Sunmax Biotechnology Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was TWD 95.497 million compared to TWD 53.006 million a year ago. Operating income was TWD 18.202 million compared to TWD 5.830 million a year ago. Net income was TWD 22.672 million compared to TWD 15.315 million a year ago. Basic earnings per share was TWD 0.42 compared to TWD 0.28 a year ago.
SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.
SUNMAX BIOTECHNOLOGY CO., LTD. 
